$CRVW
CareView Communications Inc Stock $crvw

$crvw Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000138713123007364 Filed on June 07, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$1.782M	$1.918M	$2.319M
YoY Change	-23.15%	11.25%	-1.94%
Cost Of Revenue	$705.0K	$367.2K	$737.5K
YoY Change	-4.4%	-43.91%	2.2%
Gross Profit	$1.077M	$1.551M	$1.582M
YoY Change	-31.89%	45.0%	-3.76%
Gross Profit Margin	60.44%	80.86%	68.2%
Selling, General & Admin	$866.2K	$949.4K	$1.128M
YoY Change	-23.24%	-2.85%	36.89%
% of Gross Profit	80.41%	61.22%	71.35%
Research & Development	$518.6K	$292.2K	$497.3K
YoY Change	4.3%	-45.0%	28.79%
% of Gross Profit	48.15%	18.84%	31.44%
Depreciation & Amortization	$102.5K	$137.5K	$149.4K
YoY Change	-31.38%	-11.47%	-8.25%
% of Gross Profit	9.52%	8.87%	9.45%
Operating Expenses	$2.299M	$1.632M	$1.905M
YoY Change	20.68%	-12.0%	34.42%
Operating Profit	-$516.4K	-$81.58K	-$323.2K
YoY Change	59.75%	-89.61%	-242.85%
Interest Expense	$831.3K	-$1.124M	-$2.022M
YoY Change	-141.12%	-40.99%	-25.5%
% of Operating Profit
Other Income/Expense, Net	-$830.4K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Pretax Income	-$1.347M	$283.4K	-$2.345M
YoY Change	-42.57%	-110.6%	-5.72%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	-$1.347M	$283.4K	-$2.345M
YoY Change	-42.57%	-110.6%	-5.72%
Net Earnings / Revenue	-75.57%	14.77%	-101.12%
Basic Earnings Per Share	-$0.01		-$0.02
Diluted Earnings Per Share	-$0.01	$0.00	-$16.82K
COMMON SHARES
Basic Shares Outstanding	144.8M shares	139.4M shares	141.9M shares
Diluted Shares Outstanding	144.8M shares		141.9M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$442.0K	$520.2K	$764.7K
YoY Change	-42.2%	-21.09%	115.14%
Cash & Equivalents	$442.0K	$520.2K	$764.7K
Short-Term Investments
Other Short-Term Assets	$75.91K	$71.02K	$122.4K
YoY Change	-37.97%	-69.85%	11.18%
Inventory	$285.7K	$301.4K	$269.9K
Prepaid Expenses	$75.91K	$71.02K
Receivables	$1.352M	$948.3K	$1.091M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.155M	$1.841M	$2.248M
YoY Change	-4.12%	-15.44%	12.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$540.1K	$642.6K	$1.531M
YoY Change	-64.72%	-43.58%	-26.31%
Goodwill
YoY Change
Intangibles	$760.2K	$820.1K
YoY Change		-9.92%
Long-Term Investments
YoY Change
Other Assets	$179.8K	$1.464M	$283.4K
YoY Change	-36.56%	-17.05%	54.37%
Total Long-Term Assets	$1.881M	$2.107M	$2.766M
YoY Change	-31.99%	-27.46%	-12.06%
TOTAL ASSETS
Total Short-Term Assets	$2.155M	$1.841M	$2.248M
Total Long-Term Assets	$1.881M	$2.107M	$2.766M
Total Assets	$4.037M	$3.948M	$5.014M
YoY Change	-19.49%	-22.31%	-2.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$702.5K	$650.8K	$453.9K
YoY Change	54.78%	57.07%	302.4%
Accrued Expenses	$14.52M	$13.78M	$11.47M
YoY Change	26.58%	28.09%	40.38%
Deferred Revenue	$1.517M	$890.6K
YoY Change		-9.46%
Short-Term Debt	$18.70M	$700.0K	$700.0K
YoY Change	2571.43%	0.0%	0.0%
Long-Term Debt Due	$20.00M	$50.00M	$20.00M
YoY Change	0.0%	-34.48%	-0.57%
Total Short-Term Liabilities	$55.50M	$66.08M	$34.08M
YoY Change	62.86%	-26.03%	15.45%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$14.20M	$85.24M
YoY Change	-100.0%	-49.22%	5.51%
Other Long-Term Liabilities	$19.84K	$23.48K	$446.6K
YoY Change	-95.56%	-37.5%	-16.42%
Total Long-Term Liabilities	$286.2K	$14.53M	$85.69M
YoY Change	-99.67%	-48.93%	5.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$55.50M	$66.08M	$34.08M
Total Long-Term Liabilities	$286.2K	$14.53M	$85.69M
Total Liabilities	$55.78M	$80.61M	$119.8M
YoY Change	-53.42%	-31.56%	8.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$205.3M	-$203.9M	-$200.2M
YoY Change	2.52%	3.05%
Common Stock	$403.9K	$127.3M
YoY Change		91212.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$51.75M	-$76.66M	-$114.7M
YoY Change
Total Liabilities & Shareholders Equity	$4.037M	$3.948M	$5.014M
YoY Change	-19.49%	-22.31%	-2.57%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.347M	$283.4K	-$2.345M
YoY Change	-42.57%	-110.6%	-5.72%
Depreciation, Depletion And Amortization	$102.5K	$137.5K	$149.4K
YoY Change	-31.38%	-11.47%	-8.25%
Cash From Operating Activities	-$74.55K	-$87.49K	$178.9K
YoY Change	-141.67%	-122.77%	276.71%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$58.26K	-$56.11K
YoY Change	-100.0%	-2195.68%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		$58.26K	-$56.11K
YoY Change		1995.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$3.639K	260.6K	-17.31K
YoY Change	-78.98%	22170.09%	-65.38%
NET CHANGE
Cash From Operating Activities	-$74.55K	-87.49K	178.9K
Cash From Investing Activities		58.26K	-56.11K
Cash From Financing Activities	-$3.639K	260.6K	-17.31K
Net Change In Cash	-$78.19K	231.3K	105.5K
YoY Change	-174.13%	-40.4%
FREE CASH FLOW
Cash From Operating Activities	-$74.55K	-$87.49K	$178.9K
Capital Expenditures	$0.00	-$58.26K	-$56.11K
Free Cash Flow	-$74.55K	-$29.23K	$235.0K
YoY Change	-131.72%	-107.66%	394.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	540050	usd
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-54090
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CAREVIEW COMMUNICATIONS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4659068
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	405 State Highway 121
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite B-240
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Lewisville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75067
CY2023Q1	dei	City Area Code CityAreaCode	(972)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	943-6050
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	421880748	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	441973	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	520166	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1351842	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	948328	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	285732	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	301446	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	75909	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	71020	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	2155456	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1840960	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001377149
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2023Q1	crvw	Additions To Deferred Costs AdditionsToDeferredCosts		usd
CY2022Q1	crvw	Additions To Deferred Costs AdditionsToDeferredCosts		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	642559	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	760226	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	820106	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	401066	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	434330	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	179786	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	209649	usd
CY2023Q1	us-gaap	Assets Assets	4036584	usd
CY2022Q4	us-gaap	Assets Assets	3947604	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	702490	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	650796	usd
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	20000000	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	20000000	usd
CY2023Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	700000	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	700000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	18000000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	42394168	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1805832	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	178882	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175520	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15914266	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14553277	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	55495638	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	80279593	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	266386	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	305259	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19841	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23481	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	286227	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	328740	usd
CY2023Q1	us-gaap	Liabilities Liabilities	55781865	usd
CY2022Q4	us-gaap	Liabilities Liabilities	80608333	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	403880748	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	403880748	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141880748	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141880748	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	403881	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	141881	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	153130315	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	127130055	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-205279477	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203932665	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-51745281	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-76660729	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4036584	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3947604	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1782259	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2319029	usd
CY2023Q1	us-gaap	Equipment Expense EquipmentExpense	31934	usd
CY2022Q1	us-gaap	Equipment Expense EquipmentExpense	117598	usd
CY2023Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	705042	usd
CY2022Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	737476	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	697766	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	939248	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	168419	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	189216	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	518632	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	497252	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	176831	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	161463	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2298624	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2642253	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-516365	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-323224	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	831334	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	2021784	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	887	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-830447	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2021784	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1346812	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2345008	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1346812	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2345008	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144791859	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	144791859	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141880748	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141880748	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-112698298	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	240000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	55847	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2345008	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-114747459	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-76660729	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	62260	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.10
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	26200000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1346812	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-51745281	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1346812	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2345008	usd
CY2023Q1	us-gaap	Depreciation Depreciation	102509	usd
CY2022Q1	us-gaap	Depreciation Depreciation	134940	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	59879	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14451	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	166760	usd
CY2023Q1	crvw	Amortization Of Installation Costs AmortizationOfInstallationCosts	14443	usd
CY2022Q1	crvw	Amortization Of Installation Costs AmortizationOfInstallationCosts	12072	usd
CY2023Q1	crvw	Noncash Lease Expense NoncashLeaseExpense	33265	usd
CY2022Q1	crvw	Noncash Lease Expense NoncashLeaseExpense	28499	usd
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	806728	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	62260	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	295847	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	403515	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	157794	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-15714	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-79299	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	4888	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-113138	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-15420	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-4099	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	51694	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	39536	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	802125	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	688005	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	558863	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	327529	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-35511	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-29205	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-74554	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	178896	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	56110	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56110	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	13785	usd
CY2023Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	3639	usd
CY2022Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	3522	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3639	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17307	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-78193	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	105479	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	520166	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	659228	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	441973	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	764707	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.10
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	26200000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1782259	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2319029	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1516840	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1516840	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	33461	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	68901	usd
CY2023Q1	crvw	Transfer To Expense TransferToExpense	14443	usd
CY2022Q1	crvw	Transfer To Expense TransferToExpense	12071	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	19018	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	56830	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	225461922	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	178543025	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	225461922	shares
CY2023Q1	crvw	Working Capital WorkingCapital	1242787	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
CY2023Q1	crvw	Stock Granted During Period Value Sharebased Compensation Gross Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGrossStockGrantedDuringPeriodValueSharebasedCompensationGross	12000	usd
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	0.06
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	40817477	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
CY2023Q1	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Begining SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermBegining	P5Y9M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	526425	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.06
CY2023Q1	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P9Y9M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	41017477	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
CY2023Q1	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Ending SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding	P5Y6M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	526425	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	33076810	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.13
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	423425	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	62260	usd
CY2022Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	55847	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	133336	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M12D
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	75909	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	71020	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	75909	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	71020	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	285732	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	301446	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	285732	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	301446	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13424954	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13424954	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12884904	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12782395	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	540050	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	642559	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	102509	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	134941	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1299746	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	539520	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	760226	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1299746	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	479640	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	820106	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	820106	usd
CY2023Q1	crvw	Other Assets Noncurrent Gross OtherAssetsNoncurrentGross	1812137	usd
CY2023Q1	crvw	Other Assets Accumulated Amortization OtherAssetsAccumulatedAmortization	1632351	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	179786	usd
CY2022Q4	crvw	Other Assets Noncurrent Gross OtherAssetsNoncurrentGross	1812137	usd
CY2022Q4	crvw	Other Assets Noncurrent Gross OtherAssetsNoncurrentGross	1812137	usd
CY2022Q4	crvw	Other Assets Accumulated Amortization OtherAssetsAccumulatedAmortization	1602488	usd
CY2022Q4	crvw	Other Assets Accumulated Amortization OtherAssetsAccumulatedAmortization	1602488	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	209649	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	209649	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	13708611	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	12933611	usd
CY2023Q1	crvw	Accrued Interest Related Parties AccruedInterestRelatedParties	364152	usd
CY2022Q4	crvw	Accrued Interest Related Parties AccruedInterestRelatedParties	337027	usd
CY2023Q1	crvw	Allowance System Removal Current AllowanceSystemRemovalCurrent	54802	usd
CY2022Q4	crvw	Allowance System Removal Current AllowanceSystemRemovalCurrent	54802	usd
CY2023Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	50384	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	154776	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	139041	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	139041	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1516840	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	890631	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	80436	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	43389	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15914266	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14553277	usd
CY2023Q1	crvw	Outstanding Notes And Warrants Underlying Number Of Common Shares OutstandingNotesAndWarrantsUnderlyingNumberOfCommonShares	180000000	shares
CY2009Q3	crvw	Area Of Leased Property AreaOfLeasedProperty	10578	sqft
CY2009Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2015-06-30
CY2020Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-08-31
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.148	pure
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	75887	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	82706	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	401066	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	434330	usd
CY2023Q1	crvw	Lease Assets LeaseAssets	401066	usd
CY2022Q4	crvw	Lease Assets LeaseAssets	434330	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	178882	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175520	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	266386	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	305259	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	445268	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	480779	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	161766	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	221069	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	150679	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	533515	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	88247	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	445268	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-35511	usd

Files In Submission

Name	View Source	Status
0001387131-23-007364-index-headers.html	Edgar Link	pending
0001387131-23-007364-index.html	Edgar Link	pending
0001387131-23-007364.txt	Edgar Link	pending
0001387131-23-007364-xbrl.zip	Edgar Link	pending
crvw-10q_033123.htm	Edgar Link	pending
crvw-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
crvw-20230331_cal.xml	Edgar Link	unprocessable
crvw-20230331_lab.xml	Edgar Link	unprocessable
crvw-20230331_pre.xml	Edgar Link	unprocessable
crvw-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crvw-10q_033123_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRVW
CareView Communications Inc Stock $crvw

2023 Q1 Form 10-Q Financial Statement

#000138713123007364 Filed on June 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRVW CareView Communications Inc Stock $crvw

2023 Q1 Form 10-Q Financial Statement

#000138713123007364 Filed on June 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRVW
CareView Communications Inc Stock $crvw